Acute promyelocytic leukemia Primary Prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute promyelocytic leukemia}} | {{Acute promyelocytic leukemia}} | ||
{{CMG}}; {{AE}} {{S.G.}} | {{CMG}}; {{AE}} {{S.G.}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of acute promyelocytic leukemia | * There are no established measures for the primary prevention of acute promyelocytic leukemia. | ||
* There are no available vaccines against acute promyelocytic leukemia. | |||
There are no available vaccines against acute promyelocytic leukemia . | |||
==Primary Prevention== | ==Primary Prevention== | ||
| Line 14: | Line 11: | ||
* There are no available vaccines against acute promyelocytic leukemia . | * There are no available vaccines against acute promyelocytic leukemia . | ||
* Effective measures for the primary prevention of acute promyelocytic leukemia include:<ref name="pmid250566972">{{cite journal |vauthors=Grove CS, Vassiliou GS |title=Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? |journal=Dis Model Mech |volume=7 |issue=8 |pages=941–51 |date=August 2014 |pmid=25056697 |doi=10.1242/dmm.015974 |url=}}</ref><ref name="pmid221664972">{{cite journal |vauthors=McHale CM, Zhang L, Smith MT |title=Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment |journal=Carcinogenesis |volume=33 |issue=2 |pages=240–52 |date=February 2012 |pmid=22166497 |pmc=3271273 |doi=10.1093/carcin/bgr297 |url=}}</ref> | * Effective measures for the primary prevention of acute promyelocytic leukemia include:<ref name="pmid250566972">{{cite journal |vauthors=Grove CS, Vassiliou GS |title=Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? |journal=Dis Model Mech |volume=7 |issue=8 |pages=941–51 |date=August 2014 |pmid=25056697 |doi=10.1242/dmm.015974 |url=}}</ref><ref name="pmid221664972">{{cite journal |vauthors=McHale CM, Zhang L, Smith MT |title=Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment |journal=Carcinogenesis |volume=33 |issue=2 |pages=240–52 |date=February 2012 |pmid=22166497 |pmc=3271273 |doi=10.1093/carcin/bgr297 |url=}}</ref><ref name="pmid27913456">{{cite journal |vauthors=Abedin S, Altman JK |title=Acute promyelocytic leukemia: preventing early complications and late toxicities |journal=Hematology Am Soc Hematol Educ Program |volume=2016 |issue=1 |pages=10–15 |date=December 2016 |pmid=27913456 |pmc=6142484 |doi=10.1182/asheducation-2016.1.10 |url=}}</ref><ref name="CasorelliBossa2012">{{cite journal|last1=Casorelli|first1=Ida|last2=Bossa|first2=Cecilia|last3=Bignami|first3=Margherita|title=DNA Damage and Repair in Human Cancer: Molecular Mechanisms and Contribution to Therapy-Related Leukemias|journal=International Journal of Environmental Research and Public Health|volume=9|issue=8|year=2012|pages=2636–2657|issn=1660-4601|doi=10.3390/ijerph9082636}}</ref><ref name="GreimKaden2014">{{cite journal|last1=Greim|first1=Helmut|last2=Kaden|first2=Debra A.|last3=Larson|first3=Richard A.|last4=Palermo|first4=Christine M.|last5=Rice|first5=Jerry M.|last6=Ross|first6=David|last7=Snyder|first7=Robert|title=The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment|journal=Annals of the New York Academy of Sciences|volume=1310|issue=1|year=2014|pages=7–31|issn=00778923|doi=10.1111/nyas.12362}}</ref> | ||
*White blood cell (WBC) count more than 10,000,000,000 | **[[White blood cells|White blood cell]] (WBC) count more than 10,000,000,000 | ||
*Advanced age (Age> 60) | **Advanced [[age]] (Age> 60) | ||
*Prevent to exposure benzene | **Prevent to exposure [[benzene]] and [[radiation]] | ||
==References== | ==References== | ||
Latest revision as of 13:13, 11 April 2019
|
Acute promyelocytic leukemia Microchapters |
|
Differentiating Acute promyelocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute promyelocytic leukemia Primary Prevention On the Web |
|
American Roentgen Ray Society Images of Acute promyelocytic leukemia Primary Prevention |
|
Directions to Hospitals Treating Acute promyelocytic leukemia |
|
Risk calculators and risk factors for Acute promyelocytic leukemia Primary Prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
- There are no established measures for the primary prevention of acute promyelocytic leukemia.
- There are no available vaccines against acute promyelocytic leukemia.
Primary Prevention
- There are no established measures for the primary prevention of acute promyelocytic leukemia .
- There are no available vaccines against acute promyelocytic leukemia .
- Effective measures for the primary prevention of acute promyelocytic leukemia include:[1][2][3][4][5]
- White blood cell (WBC) count more than 10,000,000,000
- Advanced age (Age> 60)
- Prevent to exposure benzene and radiation
References
- ↑ Grove CS, Vassiliou GS (August 2014). "Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?". Dis Model Mech. 7 (8): 941–51. doi:10.1242/dmm.015974. PMID 25056697.
- ↑ McHale CM, Zhang L, Smith MT (February 2012). "Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment". Carcinogenesis. 33 (2): 240–52. doi:10.1093/carcin/bgr297. PMC 3271273. PMID 22166497.
- ↑ Abedin S, Altman JK (December 2016). "Acute promyelocytic leukemia: preventing early complications and late toxicities". Hematology Am Soc Hematol Educ Program. 2016 (1): 10–15. doi:10.1182/asheducation-2016.1.10. PMC 6142484. PMID 27913456.
- ↑ Casorelli, Ida; Bossa, Cecilia; Bignami, Margherita (2012). "DNA Damage and Repair in Human Cancer: Molecular Mechanisms and Contribution to Therapy-Related Leukemias". International Journal of Environmental Research and Public Health. 9 (8): 2636–2657. doi:10.3390/ijerph9082636. ISSN 1660-4601.
- ↑ Greim, Helmut; Kaden, Debra A.; Larson, Richard A.; Palermo, Christine M.; Rice, Jerry M.; Ross, David; Snyder, Robert (2014). "The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment". Annals of the New York Academy of Sciences. 1310 (1): 7–31. doi:10.1111/nyas.12362. ISSN 0077-8923.